Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-19 @ 11:41 AM
Study NCT ID:
NCT01355393
Status:
COMPLETED
Last Update Posted:
2020-02-10
First Post:
2011-05-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer
Sponsor:
University of Washington
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER2-positive Breast Cancer | View |
| None | Male Breast Cancer | View |
| None | Recurrent Breast Cancer | View |
| None | Stage II Breast Cancer | View |
| None | Stage IIIA Breast Cancer | View |
| None | Stage IIIB Breast Cancer | View |
| None | Stage IIIC Breast Cancer | View |
| None | Stage IV Breast Cancer | View |